Topics

Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

10:31 EDT 11 Oct 2019 | Bionity

Merck announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed. “Chimeric antigen receptor T cell therapies, or CAR-T fo...

Original Article: Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

NEXT ARTICLE

More From BioPortfolio on "Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...